Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region

  • Luca Gambini,
  • Luca Rizzi,
  • Alessandro Pedretti,
  • Orazio Taglialatela-Scafati,
  • Mario Carucci,
  • Andrea Pancotti,
  • Corinna Galli,
  • Martin Read,
  • Emanuele Giurisato,
  • Sergio Romeo,
  • Ilaria Russo
  • Article
  • Metrics
  • Comments
  • Media Coverage

The following information is missing from the Funding section: Work by IR and co-workers is primarily supported by Wellcome Trust Infrastructure Support Fund of the University of Manchester and the European Research Council.

There is an error in the Acknowledgments section. This section should read: We thank Jacobus Pharmaceutical Company, Princeton, NJ for the kind provision of WR99210 and ATCC (MR4) for BiP antibody, D. Taylor for HRPII antibody, L. Romani and A. Vecchiarelli for fluorimeter access; and B. Sleebs and J. Boddey for WEHI916.

Reference

  1. 1. Gambini L, Rizzi L, Pedretti A, Taglialatela-Scafati O, Carucci M, Pancotti A, et al. (2015) Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region. PLoS ONE 10(11): e0142509. pmid:26566224

Citation: Gambini L, Rizzi L, Pedretti A, Taglialatela-Scafati O, Carucci M, Pancotti A, et al. (2016) Correction: Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region. PLoS ONE 11(1): e0146627. https://doi.org/10.1371/journal.pone.0146627

Published: January 4, 2016

Copyright: © 2016 Gambini et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited